King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

0
Player Avatar tone17 (44.22) Submitted: 5/20/2009 8:17:28 PM : Outperform Start Price: $8.96 KG Score: +9.73

New meds

Featured Broker Partners


Advertisement